May 17-18 | San Diego, USA

Proveris is an expertise sponsor of The Novel Formulation & Delivery Summit which will be held from May 17-18.

Our presentation entitled ‘Using Quality by Design (QbD) to Accelerate Nasal Drug Product Development’ discusses in vitro testing approaches that accommodate the complexity of combination products. The approach incorporates QbD into the very early development phase and facilitates a streamlined scale-up during commercialization.

If you would like to learn more and schedule a private meeting with us, email us at

The Novel Nasal Formulation & Delivery Summit is a unique forum set to unite 60 plus pioneers in nasal drug development. Speakers will reveal enlightening content focusing on novel formulation and delivery techniques for both acute and chronic disease indications. Attendees will learn how to propel non-invasive therapeutics through nasal drug delivery route and increase patient adherence across the next generations of vaccines, CNS, and respiratory indications.

Learn more and register HERE.